- Équipe
- Equipe 2 « Biomarqueurs et cibles thérapeutiques »
- Fonction
- Représentante des EC titulaires
Affiliations de recherche
Publications
Publications rapprochées automatiquement à partir du nom d’auteur.
GW501516-Mediated Targeting of Tetraspanin 15 Regulates ADAM10-Dependent N-Cadherin Cleavage in Invasive Bladder Cancer Cells
Barbaud, Alexandre, Lascombe, Isabelle, Pechery, Adeline, Arslan, Sergen, Kleinclauss, Francois, Fauconnet, Sylvie
Concomitant decrease of E- and A-FABP expression predicts worse survival in urothelial bladder cancer patients
Saizonou, Ines, Lascombe, Isabelle, Monnien, Franck, Bedgedjian, Isabelle, Kleinclauss, Francois, Algros, Marie-Paule, Fauconnet, Sylvie
Molecular and nanoscale evaluation of N-cadherin expression in invasive bladder cancer cells under control conditions or GW501516 exposure
Elie-Caille, Celine, Lascombe, Isabelle, Pechery, Adeline, Bittard, Hugues, Fauconnet, Sylvie
Down-regulation of A-FABP predicts non-muscle invasive bladder cancer progression: investigation with a long term clinical follow-up
Mathis, Christel, Lascombe, Isabelle, Monnien, Franck, Bittard, Hugues, Kleinclauss, Francois, Bedgedjian, Isabelle, Fauconnet, Sylvie, Valmary-Degano, Severine
Cell death and restoration of TRAIL-sensitivity by ciglitazone in resistant cervical cancer cells
Plissonnier, Marie-Laure, Fauconnet, Sylvie, Bittard, Hugues, Mougin, Christiane, Rommelaere, Jean, Lascombe, Isabelle
Apoptotic effect of the selective PPARβ/δ agonist GW501516 in invasive bladder cancer cells
Pechery, Adeline, Fauconnet, Sylvie, Bittard, Hugues, Lascombe, Isabelle
The PPARβ agonist L-165041 promotes VEGF mRNA stabilization in HPV18-harboring HeLa cells through a receptor-independent mechanism
Roche, Emmanuelle, Lascombe, Isabelle, Bittard, Hugues, Mougin, Christiane, Fauconnet, Sylvie
The Antidiabetic Drug Ciglitazone Induces High Grade Bladder Cancer Cells Apoptosis through the Up-Regulation of TRAIL
Plissonnier, Marie-Laure, Fauconnet, Sylvie, Bittard, Hugues, Lascombe, Isabelle
SPLICE VARIANT VASCULAR ENDOTHELIAL GROWTH FACTOR-A LEVEL AS PROGNOSTIC INDICATOR OF PROGRESSION IN BLADDER CANCER
Bittard, Hugues, Lascombe, Isabelle, Bernardini, Stephane, Chabannes, Eric, Fauconnet, Sylvie
INSIGHTS ON PATHWAYS OF THIAZOLIDINEDIONES -PROMOTED APOPTOSIS IN ``TUMOR NECROSIS FACTOR-RELATED APOPTOSIS INDUCING LIGAND''-RESISTANT MALIGNANT UROTHELIAL CELLS
Lascombe, Isabelle, Plissonnier, Marie-Laure, Bittard, Hugues, Fauconnet, Sylvie
ADIPOCYT-FATTY ACID BINDING PROTEIN, A POTENTIAL PROGNOSTIC MARKER OF BLADDER TRANSITIONAL CELL CARCINOMA
Fauconnet, Sylvie, Boiteux, Guillaume, Bittard, Hugues, Lascombe, Isabelle
Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines
Wallerand, Herve, Cai, Ying, Wainberg, Zev A., Garraway, Isla, Lascombe, Isabelle, Nicolle, Gaelle, Thiery, Jean-Paul, Bittard, Hugues, Radvanyi, Francois, Reiter, Robert R.
Insights on distinct pathways of thiazolidinediones (PPARγ ligand)-promoted apoptosis in TRAIL-sensitive or -resistant malignant urothelial cells
Plissonnier, Marie Laure, Fauconnet, Sylvie, Bittard, Hugues, Lascombe, Isabelle
Expression analysis of VEGF-A and VEGF-B: Relationship with clinicopathological parameters in bladder cancer
Fauconnet, Sylvie, Bernardini, Stephane, Lascombe, Isabelle, Boiteux, Guillaume, Clairotte, Anne, Monnien, Franck, Chabannes, Eric, Bittard, Hugues
A-FABP, a candidate progression marker of human transitional cell carcinoma of the bladder, is differentially regulated by PPAR in urothelial cancer cells
Boiteux, Guillaume, Lascombe, Isabelle, Roche, Emmanuelle, Plissonnier, Marie-Laure, Clairotte, Anne, Bittard, Hugues, Fauconnet, Sylvie
The human papillomavirus type 18 E6 oncoprotein induces Vascular Endothelial Growth Factor 121 (VEGF121) transcription from the promoter through a p53-independent mechanism
Clere, Nicolas, Bermont, Laurent, Fauconnet, Sylvie, Lascombe, Isabelle, Saunier, Maelle, Vettoretti, Lucie, Plissonnier, Marie-Laure, Mougin, Christiane